Fitbit Selected for National Institutes of Health (NIH) Precision Medicine Research Program with The Scripps Research Institu...
08 November 2017 - 1:00AM
Business Wire
10,000 Fitbit devices to be used for research
in national program
Fitbit (NYSE:FIT), the leading global wearables brand, announced
today it has been selected as the first wearable for use in the
national All of Us Research Program established by the White House
in 2015. This project is funded by a supplement to a funding award
from the National Institutes of Health (NIH) to The Scripps
Research Institute (TSRI).
All of Us seeks to enroll one million or more participants to
accelerate research that may improve the ability to prevent and
treat disease based on individual characteristics. Researchers will
use data gathered from the program to learn more about how
individual differences in lifestyle, environment and biological
makeup can influence health and disease.
As a subset of the All of Us Research Program, the Scripps
Translational Science Institute (STSI) leads The Participant
Center, a unit tasked with enrolling and engaging diverse
populations across the country. Through this network, STSI will
provide up to 10,000 Fitbit Charge 2™ and Fitbit Alta HR™ devices
to a representative sample of All of Us volunteers for a one-year
study. At the end of the study, the researchers will provide
recommendations on how the devices could be more broadly
incorporated into the All of Us Research Program.
Additionally, the study will generate a data set that presents a
unique opportunity to explore the relationship between health
indicators such as physical activity, heart rate and sleep in
conjunction with other critical health outcomes that will be
captured as part of All of Us.
“As part of the global shift towards precision medicine,
wearable data has the potential to inform highly personalized
healthcare,” said Adam Pellegrini, General Manager of Fitbit Health
Solutions. “Through this historic initiative, we will be able to
see the role that Fitbit data can play on the path to better
understanding how individualization can help to prevent and treat
disease.”
Features of Fitbit Devices Are Vitally Important for
Researchers
After evaluating consumer wearables in the market, the STSI team
selected Fitbit based on its review of peer-reviewed validation
studies and the fact that Fitbit devices are the most popular
wearables in health research worldwide.
“The Fitbit devices selected track a combination of physical
activity, sleep, and heart rate parameters,” said Eric Topol,
Founder and Director of STSI. “The popularity of Fitbit devices
among millions of Americans, combined with their ease of use,
including multi-day battery life and broad compatibility with
smartphones, made Fitbit a natural choice for this pilot
program.”
An analysis1 published by the Federation of American Societies
for Experimental Biology (FASEB) Journal found that Fitbit devices
are the most commonly used tracker in biomedical research,
including published work (89%), clinical trials (83%), and
NIH-funded research (95%). To-date, more than 470 published
studies2 have utilized a Fitbit device, which is more than any
other consumer wearable brand3, including use of wearables in areas
such as diabetes, cardiovascular health, oncology, mental health
and post-surgery.
“Most of what researchers know is based on intermittent
snapshots of health in an artificial setting or based on personal
recall,” said Steven Steinhubl, MD, Cardiologist and Director of
Digital Medicine at STSI. “Through this research program, we’ll
have access to comprehensive activity, heart rate and sleep data
that may help us better understand the relationship between
lifestyle behaviors and health outcomes and what that means for
patients on an individualized basis.”
About Fitbit, Inc. (NYSE:FIT)
Fitbit helps people lead healthier, more active lives by
empowering them with data, inspiration and guidance to reach their
goals. As the leading global wearables
brand, Fitbit designs products and experiences that track
and provide motivation for everyday health and fitness. Fitbit’s
diverse line of innovative and popular products
includes Fitbit Surge®, Fitbit Blaze®, Fitbit
Charge 2®, Alta HR™, Alta®, Fitbit Flex 2®, Fitbit One®
and Fitbit Zip® activity trackers, as well as the Fitbit
Ionic™ smartwatch, Fitbit Flyer™ wireless headphones and Fitbit
Aria® and Fitbit Aria 2™ Wi-Fi Smart Scales. Fitbit products
are carried in 46,000 retail stores across 78 countries around the
globe. Powered by one of the world’s largest social fitness
networks and databases of health and fitness data,
the Fitbit platform delivers personalized experiences,
insights and guidance through leading software and interactive
tools, including the Fitbit and Fitbit Coach
apps, Guided Health Programs, and the Fitbit OS for smartwatches.
Fitbit Health Solutions develops health and wellness solutions
designed to help increase engagement, improve health outcomes, and
drive a positive return for employers, health plans and health
systems.
Fitbit and the Fitbit logo are trademarks or registered
trademarks of Fitbit, Inc. in the U.S. and other countries.
Additional Fitbit trademarks can be found at
www.fitbit.com/legal/trademark-list. Third-party trademarks are the
property of their respective owners.
Connect with us
on Facebook, Instagram or Twitter and
share your Fitbit experience.
All of Us is a service mark of the U.S. Department of Health and
Human Services.
1 http://www.fasebj.org/content/31/1_Supplement/1020.24.long
2 https://www.fitabase.com/research-library/
3 http://www.fasebj.org/content/31/1_Supplement/1020.24.long
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171107005646/en/
Fitbit, Inc.Jen Ralls, 415-941-0037PR@fitbit.com
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jul 2023 to Jul 2024